Tech Company Financing Transactions

Pretzel Therapeutics Funding Round

Arch Venture Partners, Angelini Ventures and Cambridge Enterprise invested in a $72.5 million Series A funding round for Pretzel Therapeutics. The financing round was announced on 9/12/2022.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

1601 Trapelo Rd
Waltham, MA 02451
USA

Phone

Undisclosed

Website

www.pretzeltx.com

Email Address

[email protected]

Overview

Pretzel was founded by some of the world's foremost researchers in mitochondrial biology and is led by accomplished experts in drug discovery, drug development, and company foundation. Our deep expertise in mitochondrial biology enables us to potentially address a wider range of diseases driven by mitochondrial dysfunction than ever before.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Jay Parrish

        

Chief Operating Officer

Baruch Harris

        

Chief Scientific Officer

Gabriel Martinez

        

Co-Founder

Claes Gustafsson

        

Co-Founder

Michal Minczuk

        

Vice President

Andrew Griffin

        

Browse more venture capital transactions:

Prev: 9/12/2022: Armut venture capital transaction
Next: 9/12/2022: Stashaway venture capital transaction

Share this article

Where The Data Comes From

We do our best to record all VC transactions involving tech companies. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary